Skip to content

Category Archives: Treat obesity and type 2 diabetes

Novel Gastrointestinal Interventional Therapies > Endolumenal application > GI Dynamics > Gut-Lining Device > Combats Diabetes > Obesity Clinical Trial > Reduced blood sugar > More invasive procedures might carry more risk > Harvard Medical School > Reversible > Device can be retrieved via the mouth > First World Congress on Interventional Therapies for Type 2 Diabetes > EndoBarrier Gastrointestinal Liner Data > Patients with Type 2 Diabetes > Presented at the First World Congress > Interventional Therapies for Type 2 Diabetes

Thursday, September 18, 2008

Has the EndoBarrier potential to provide immediate metabolic control with less risk? Are these the most exciting and promising device data from endoscopic devices? Has this disease has reached epidemic proportions around the globe? Is there a substantial unmet need for a simple and safe approach for patients to achieve metabolic control?

IIP > read on […]

Filed in Prospective randomized sham-controlled clinical trial, Clinical-stage medical device company, Deliver immediate metabolic control, Modifying metabolic pathways, Endoluminal Therapies for Type 2 Diabetes, Keynote lecture, Novel Gastrointestinal Interventional Therapies, Lee M Kaplan, Weight Center, Orally delivered, Removable device, Health policy makers, Public health authorities and insurers, Seize the opportunity, Novel interventional therapies, Forum for the medical community, Comprehensive and multidisciplinary forum, Lines a portion of the small intestine, Top-tier investors, Catalyst Health Ventures, Treat obesity and type 2 diabetes, Noninvasive device, Domain Associates, Johnson & Johnson Development Corporation, Polaris Venture Partners, Bariatric surgery, Cutlass Capital, Advanced Technology Ventures, New York Presbyterian Hospital, Weill Cornell Medical College, GI Dynamics, Type 2 diabetes, Clinical Trial, Patients with Type 2 Diabetes, First World Congress on Interventional Therapies, Pioneering new approaches to treating metabolic disorde, Medical Device Company, EndoBarrier Gastrointestinal Liner, Gastrointestinal surgery, Resulting in weight loss, Improved glycemic control, Massachusetts General Hospital | Comments Off